AB70 - Otalgia or Ear Effusion: Complete Coding Guide
1. Introduction
Otalgia, or ear pain, and ear effusion represent two of the most frequent complaints in primary care and specialized otolaryngology services. The ICD-11 code AB70 was developed specifically to classify these conditions when they do not fit into more specific categories of auricular pathologies, such as acute infectious processes or defined structural diseases.
Otalgia can manifest as primary pain, originating from the structures of the ear itself, or as referred pain from other nearby anatomical regions. Ear effusion, on the other hand, is characterized by the accumulation of fluid in the middle ear, which may or may not be associated with painful symptoms. Both conditions can significantly affect patients' quality of life, interfering with hearing, sleep, and daily activities.
The clinical importance of this code lies in the need to adequately document auricular symptoms that do not correspond to more specific diagnoses or that are under investigation. The prevalence of these complaints is high across all age groups, although it is particularly common in children and young adults. In clinical settings, otalgia represents a diagnostic challenge due to the complex innervation of the auricular region and the multiple potential causes.
Correct coding using AB70 is critical for various aspects of medical practice: it allows appropriate epidemiological tracking of these conditions, facilitates communication among healthcare professionals, ensures appropriate reimbursement for services provided, and contributes to healthcare quality studies. Furthermore, accurate documentation aids in longitudinal patient follow-up and in identifying patterns that may indicate more complex underlying conditions.
2. Correct ICD-11 Code
Code: AB70
Description: Ear pain or ear effusion
Parent category: null - Disorders of the ear, not classified elsewhere
The code AB70 belongs to the chapter of ear disorders that do not fit into more specific classifications. This code was created to capture auricular symptoms and signs that represent legitimate reasons for medical consultation, but that do not meet criteria for more definitive diagnoses at the time of evaluation.
The hierarchical structure of ICD-11 positions this code within general ear disorders, recognizing that it is not always possible or appropriate to establish a definitive etiological diagnosis on the first evaluation. The code allows for adequate documentation of the patient's chief complaint while complementary investigations are performed or while the clinical presentation evolves to allow for more specific classification.
It is important to understand that AB70 does not represent a diagnostic failure, but rather a realistic recognition that ear symptoms may require time and additional evaluation for complete characterization. This code should be used when the clinical presentation does not clearly align with more specific diagnoses available in the classification, ensuring that no relevant clinical information is lost in the documentation process.
3. When to Use This Code
The AB70 code should be applied in specific clinical situations where otalgia or ear effusion represents the principal condition, without evidence of more defined pathological processes. Below, we present detailed practical scenarios:
Scenario 1: Nonspecific Otalgia in Initial Evaluation
A patient presents with recent-onset ear pain, without history of trauma or exposure to obvious risk factors. On otoscopic examination, the tympanic membrane is intact, without signs of acute inflammation, perforation, or evident effusion. There are no signs of external auditory canal infection. The patient does not present with systemic symptoms such as fever. In this case, while other causes are being investigated, AB70 is appropriate for documenting the chief complaint.
Scenario 2: Middle Ear Effusion without Characteristics of Otitis Media
A child is evaluated following a complaint of hearing loss. Otoscopy reveals the presence of fluid behind the tympanic membrane, which maintains its integrity and does not present significant hyperemia or bulging. There is no recent history of upper respiratory infection or ear pain. Effusion is present, but does not meet criteria for acute or chronic otitis media at the time of evaluation. AB70 appropriately documents this presentation.
Scenario 3: Referred Otalgia Under Investigation
An adult patient reports pain in the ear region, but complete examination of the external ear, auditory canal, and tympanic membrane reveals no abnormalities. The pain may be related to temporomandibular joint dysfunction, dental pathology, or other causes of referred pain, but these have not yet been confirmed. While investigation proceeds, AB70 captures the auricular symptom presented.
Scenario 4: Sensation of Ear Fullness with Minimal Effusion
A patient describes a sensation of plugged or full ear, with mild discomfort. Examination reveals mild retraction of the tympanic membrane and possible presence of serous fluid in small quantity in the middle ear, visible on pneumatic otoscopy. There are no signs of active infection or significant inflammation. This presentation justifies the use of AB70.
Scenario 5: Otalgia Following Air Travel or Pressure Change
Following airplane travel or diving, a patient develops ear pain and sensation of pressure. Examination may reveal mild hyperemia of the tympanic membrane or small effusion, without signs of severe barotrauma or perforation. The condition does not clearly fit into specific traumatic categories, making AB70 appropriate.
Scenario 6: Follow-up of Persistent Effusion
A patient returns for follow-up consultation after treatment of a previous ear condition. Residual effusion remains in the middle ear, but without signs of active infection or acute inflammatory process. The effusion is an isolated finding that requires monitoring. AB70 appropriately documents this clinical situation.
4. When NOT to Use This Code
It is fundamental to recognize situations where AB70 should not be applied, directing coding to more specific and appropriate categories:
Exclusion for Otitis Media (code 1079654421):
When there is clear evidence of inflammatory or infectious process of the middle ear, characterized by hyperemic tympanic membrane, bulging, with purulent effusion, or when there are systemic symptoms of infection such as fever, irritability in children, or intense throbbing pain, the appropriate diagnosis is otitis media, not AB70. The presence of tympanic perforation with purulent otorrhea also excludes the use of AB70. Any presentation that meets diagnostic criteria for acute otitis media, otitis media with effusion associated with infection, or chronic otitis media should be coded with the specific code for these conditions.
Exclusion for Primary Chronic Orofacial Pain (code 2104869000):
When pain in the auricular region is part of a primary chronic orofacial pain syndrome, with characteristics of persistent pain lasting more than three months, without identifiable structural cause, and with characteristics of primary chronic pain, the appropriate code is 2104869000. Patients with a history of chronic facial pain that extends to the auricular region should not be coded as AB70, especially when there are components of central sensitization or characteristics of neuropathic pain.
Exclusion for Secondary Headache or Chronic Orofacial Pain (code 2116703819):
If otalgia is clearly secondary to another identifiable condition, such as temporomandibular dysfunction, dental pathology, neuralgia, or neoplastic process of the head and neck region, and meets criteria for secondary headache or chronic orofacial pain, code 2116703819 should be used. This code captures the secondary nature of the pain, differentiating it from primary or nonspecific auricular symptoms.
Other Important Exclusions:
AB70 should not be used when there is an established diagnosis of auricular trauma, foreign body in the auditory canal, otitis externa, impacted cerumen, traumatic tympanic perforation, or any other auricular condition with a specific available code. The presence of definitive otoscopic findings that characterize other specific pathologies always directs to more precise codes. Additionally, when otalgia is a minor symptom in the context of more significant systemic disease, the primary condition should be coded as a priority.
5. Step-by-Step Coding Process
Step 1: Assess Diagnostic Criteria
Appropriate coding with AB70 begins with a complete and systematic clinical evaluation. The physician should perform a detailed history, including pain characteristics (location, intensity, quality, aggravating and relieving factors), symptom duration, associated symptoms, and relevant medical history.
Physical examination should include careful inspection of the external ear, complete otoscopy of both ears, assessment of tympanic membrane mobility (pneumatic otoscopy when available), palpation of the periauricular and mastoid regions, and examination of the temporomandibular joint. Basic hearing assessment through simple tests such as whisper or tuning fork can provide valuable information.
Necessary instruments include an otoscope with adequate illumination, ear specula of various sizes, and ideally a pneumatic otoscope to assess tympanic mobility. In some settings, tympanometry may be useful to confirm the presence of effusion and assess Eustachian tube function.
Documenting the absence of signs that would indicate more specific diagnoses is as important as recording positive findings. Confirmation that there are no signs of acute otitis media, external otitis, trauma, or other specific conditions justifies the use of AB70.
Step 2: Verify Specifiers
Although AB70 does not have extensive formal subcategories in the ICD-11 structure, clinical documentation should include specifiers that adequately characterize the presentation. Record whether the main symptom is otalgia, effusion, or both.
For otalgia, document the intensity (mild, moderate, severe), duration (acute if less than three weeks, subacute if three to twelve weeks), laterality (right unilateral, left unilateral, or bilateral), and temporal pattern (continuous, intermittent, or episodic).
For effusion, specify the laterality, type of fluid when possible to determine by otoscopy (serous, mucous), and impact on hearing. Document whether there are associated symptoms such as fullness sensation, autophony, or tinnitus.
These specifiers, although they do not change the main code, are essential for appropriate clinical communication, therapeutic planning, and monitoring patient progression.
Step 3: Differentiate from Other Codes
Differentiation from AB71 (Degenerative or Vascular Disorders of the Ear):
AB71 is used for conditions characterized by degenerative or vascular processes of the ear, such as otosclerosis, presbycusis, or specific vascular conditions. The key difference is that AB71 involves progressive and generally irreversible structural or functional changes, whereas AB70 represents symptoms that may be transitory and not necessarily associated with structural degeneration. If there is evidence of a documented degenerative process, use AB71; if there are only symptoms without evidence of degeneration, use AB70.
Differentiation from AB72 (Acoustic Nerve Disorders):
AB72 applies specifically to pathologies of the eighth cranial nerve, including vestibular neuritis, acoustic neuroma, or other neuropathies of the vestibulocochlear nerve. The main difference is that AB72 requires evidence of specific neural dysfunction, usually with vestibular symptoms (vertigo, imbalance) or documented sensorineural hearing loss, often with confirmation through audiometry and auditory evoked potentials. AB70 does not involve proven neural dysfunction.
Differentiation from AB73 (Ear Atrophy):
AB73 is reserved for conditions characterized by atrophy or tissue loss of auricular structures. The key difference is the presence of visible or documented atrophic changes, such as tympanic membrane atrophy, auditory canal atrophy, or other structural changes characterized by tissue loss. AB70 does not present these atrophic structural changes and represents functional symptoms or effusion without associated atrophy.
Step 4: Necessary Documentation
Appropriate documentation to justify the use of AB70 should include:
Checklist of Mandatory Information:
- Date and time of evaluation
- Detailed chief complaint in the patient's own words
- History of present illness with clear chronology
- Associated symptoms and their temporal relationship
- Physical examination findings of the external ear
- Detailed description of bilateral otoscopy
- Assessment of tympanic membrane mobility when performed
- Results of basic hearing tests performed
- Explicit exclusion of main differential diagnoses
- Justification for not using more specific codes
- Proposed management and follow-up plan
The record should allow another professional to clearly understand why AB70 was chosen instead of more specific codes, demonstrating that the evaluation was complete and that the coding adequately reflects the clinical presentation.
6. Complete Practical Example
Clinical Case
A 28-year-old female patient presents to the clinic with a complaint of right ear pain for five days. She reports that the pain started gradually, without an identifiable triggering factor, describing it as a sensation of pressure and discomfort, without pulsatile characteristics. There was no recent exposure to water, trauma, or manipulation of the ear. She denies fever, otorrhea, or upper respiratory symptoms. She mentions an occasional sensation of "plugged ear" on the affected side.
The patient has no history of recurrent otitis in childhood or adulthood. There is no history of previous otologic surgeries. She works in an office setting, without occupational exposure to intense noise. She denies use of ototoxic medications. She mentions an episode of a cold approximately three weeks ago, which has completely resolved.
On physical examination, the patient is in good general condition, afebrile, without signs of toxemia. Inspection of the right external ear reveals no abnormalities, without edema, hyperemia, or skin lesions. Palpation of the auricle and periauricular region does not elicit significant pain. There is no pain on palpation of the mastoid region.
On otoscopy of the right ear, the external auditory canal is patent, without signs of inflammation, edema, or discharge. The tympanic membrane is intact, with mild opacification and discrete retraction. An air-fluid level is observed suggestive of a small amount of fluid in the middle ear. There is no significant hyperemia of the tympanic membrane, bulging, or perforation. Otoscopy of the left ear reveals a completely normal examination.
Evaluation with pneumatic otoscopy demonstrates reduced mobility of the right tympanic membrane, confirming the presence of effusion. Whisper test suggests mild reduction in hearing acuity on the right compared to the left. There are no signs of vestibular involvement or other neurologic deficits.
Coding Step by Step
Criteria Analysis:
The patient presents with right unilateral otalgia of five days duration, associated with middle ear effusion evidenced by an air-fluid level, tympanic retraction, and reduced mobility on pneumatic otoscopy. The absence of significant acute inflammatory signs, fever, purulent otorrhea, or intense hyperemia of the tympanic membrane excludes the diagnosis of acute otitis media.
The history of a cold three weeks prior suggests possible residual Eustachian tube dysfunction as a pathophysiologic mechanism, but the current presentation does not characterize an active infectious process. The effusion is serous, not purulent, and the clinical presentation is of mild to moderate intensity.
Code Selected: AB70
Complete Justification:
AB70 is the most appropriate code because the patient presents with both otalgia and ear effusion, which are exactly the conditions covered by this code. The presentation does not meet criteria for otitis media (code 1079654421) due to the absence of significant acute inflammatory signs and features of active infection. There is no evidence of degenerative or vascular process (AB71), acoustic nerve dysfunction (AB72), or auricular atrophy (AB73).
The pain is not chronic nor does it present characteristics of primary orofacial pain (code 2104869000), and there is no evidence that it is secondary to another systemic or head and neck condition that would justify a secondary headache code (code 2116703819). The effusion present is an objective finding that, combined with the otalgia, fully justifies the use of AB70.
Complementary Codes:
In this specific case, there is no need for complementary codes, as AB70 adequately captures the main clinical condition. If there were relevant coexisting conditions, such as allergic rhinitis that could contribute to Eustachian tube dysfunction, an additional code could be considered.
Documented Management Plan:
Topical nasal decongestant was prescribed to improve Eustachian tube function, instructions on Valsalva maneuver were given, and a follow-up appointment was scheduled in two weeks for reevaluation. If there is persistence or worsening of symptoms, further investigation with audiometry and tympanometry will be considered. The patient was instructed on warning signs that would indicate the need for earlier return.
7. Related Codes and Differentiation
Within the Same Category
AB71: Degenerative or Vascular Disorders of the Ear
When to use AB71 vs. AB70: AB71 should be used when there is evidence of progressive degenerative process or vascular alteration of the ear, such as otosclerosis with stapes fixation, documented presbycusis with age-related sensorineural hearing loss, or specific vascular conditions affecting the inner ear. Use AB70 when symptoms are acute or subacute, potentially reversible, and there is no evidence of progressive structural degeneration.
Main difference: AB71 involves progressive and generally irreversible structural or functional changes with degenerative or vascular pathophysiological basis, whereas AB70 represents symptoms that may be transitory, functional, or related to acute conditions without established structural degeneration.
AB72: Acoustic Nerve Disorders
When to use AB72 vs. AB70: AB72 is appropriate when there is proven dysfunction of the eighth cranial nerve, manifesting as sensorineural hearing loss, vestibular symptoms (vertigo, nystagmus), or when there is evidence of neural injury through complementary examinations such as magnetic resonance imaging showing acoustic neuroma or abnormal auditory evoked potentials. Use AB70 when otalgia or effusion is not associated with signs of vestibulocochlear neuropathy.
Main difference: AB72 requires evidence of specific acoustic nerve neural compromise, often with vestibular manifestations and/or sensorineural hearing loss, whereas AB70 does not involve proven neural dysfunction and typically presents with normal conductive hearing or only mildly compromised by effusion.
AB73: Atrophy of the Ear
When to use AB73 vs. AB70: AB73 is indicated when there is documented atrophy of auricular structures, such as atrophy of the tympanic membrane (extensive myringosclerosis, thinned and atrophic tympanic membrane), atrophy of the auditory canal, or other visible atrophic changes. Use AB70 when there are no atrophic changes and the presentation is characterized by functional symptoms or effusion without tissue loss.
Main difference: AB73 is characterized by permanent visible atrophic structural changes on examination or documented by imaging, whereas AB70 represents symptoms or findings that do not involve tissue atrophy and may be completely reversible.
Differential Diagnoses
The main conditions that may be confused with AB70 include external otitis, which is differentiated by the presence of inflammation of the external auditory canal with pain on traction of the auricle; temporomandibular dysfunction, which presents with pain related to mastication and tenderness on palpation of the TMJ; and neuralgia, which typically manifests as lancinating, shock-like pain following specific neural distribution. Clear distinction is based on detailed history, complete physical examination, and when necessary, targeted complementary examinations.
8. Differences with ICD-10
In ICD-10, the conditions covered by AB70 were generally coded under H92 (Otalgia and otorrhea), specifically H92.0 for otalgia and H92.1 for otorrhea, or under H65 for nonsuppurative otitis media when effusion was present. ICD-10 did not have a single code that specifically combined otalgia and effusion in the way AB70 does.
The main changes in ICD-11 include the creation of a more specific category that recognizes the frequent coexistence of otalgia and effusion, allowing more precise coding when both conditions are present. The hierarchical structure was reorganized to better reflect contemporary clinical practice and facilitate differentiation of specific conditions versus nonspecific symptomatic presentations.
The practical impact of these changes is significant: coding becomes more intuitive and aligned with the actual clinical presentation of patients, reducing ambiguity in code selection. The ability to adequately capture auricular symptoms that do not fit into more specific diagnostic categories improves the quality of epidemiological data and facilitates studies on patterns of presentation and evolution of these conditions. For professionals familiar with ICD-10, the transition requires understanding that AB70 offers a more specific option for situations previously coded in a more generic manner.
9. Frequently Asked Questions
1. How is the diagnosis of otalgia or ear effusion made?
The diagnosis is established through detailed history taking and complete physical examination, with emphasis on otoscopy. The clinical history should explore characteristics of pain, duration of symptoms, triggering factors, and associated symptoms. Otoscopic examination is fundamental for identifying effusion through signs such as air-fluid level, opacification, or retraction of the tympanic membrane. Pneumatic otoscopy, when available, confirms the presence of fluid by reduced mobility of the tympanic membrane. In selected cases, tympanometry and audiometry can provide complementary information. Differential diagnosis with other auricular conditions is essential to ensure that AB70 is the appropriate code.
2. Is treatment available in public health systems?
Treatment for otalgia and ear effusion is generally available in public health systems, as it mainly involves conservative measures and low-cost medications. Therapeutic options include watchful waiting in mild cases, nasal decongestants to improve Eustachian tube function, analgesics for pain control, and occasionally antihistamines when there is an allergic component. Most cases resolve spontaneously or with conservative treatment. More complex procedures, such as myringotomy with insertion of ventilation tubes, are reserved for cases of persistent effusion and are generally available in specialized otolaryngology services within public health systems.
3. How long does treatment last?
The duration of treatment varies according to the underlying cause and individual response. Cases of mild otalgia without significant effusion often resolve within a few days to one week with symptomatic treatment. Middle ear effusions may persist for several weeks, with average resolution period between four to six weeks, although some cases may last up to three months. Medical follow-up is recommended every two to four weeks to monitor progression. If effusion persists beyond three months, additional investigation and more specific interventions may be necessary. Symptomatic medication treatment is generally maintained for one to two weeks, with reassessment to determine need for continuation.
4. Can this code be used in medical certificates?
Yes, AB70 can be used in medical certificates when otalgia or ear effusion justifies absence from activities. The need for absence depends on the intensity of symptoms and the nature of the patient's activities. Intense otalgia may justify absence of one to three days, especially if there is impairment of concentration or need for analgesics that cause drowsiness. Effusion with hearing impairment may justify temporary absence from activities requiring precise hearing or in noisy environments. The certificate should specify the ICD-11 code AB70 and the recommended absence period based on individual clinical assessment. Adequate documentation in the medical record should support the decision for absence.
5. Can children receive this diagnosis?
Yes, children frequently receive the diagnosis coded as AB70, especially considering that middle ear effusion is common in the pediatric population due to the anatomy of the Eustachian tube in childhood. However, it is important to carefully differentiate from acute otitis media, which is very prevalent in children and requires a specific code. In children, effusion may affect language development if persistent, making follow-up particularly important. Evaluation in young children may be challenging due to difficulty with cooperation for examination, but careful otoscopy remains essential. Parents and caregivers should be instructed about warning signs that would indicate need for urgent reevaluation.
6. When is reevaluation necessary?
Reevaluation is recommended in two to four weeks for cases of effusion or otalgia that do not resolve quickly. Earlier return is indicated if there is worsening of symptoms, development of fever, purulent otorrhea, progressive hearing loss, or vestibular symptoms. For effusions that persist beyond six to eight weeks, referral to an otolaryngology specialist should be considered for evaluation of need for more specific intervention. Children with persistent effusion require closer monitoring due to the risk of impact on language development. Reevaluation should include repeated otoscopy and, when appropriate, audiometry to objectively document progression.
7. Is there a relationship between allergies and this diagnosis?
Yes, there is a well-established relationship between allergic conditions, particularly allergic rhinitis, and the development of middle ear effusion. Allergic inflammation of the upper airways can cause edema of the Eustachian tube mucosa, impairing its ventilation and drainage function of the middle ear. This predisposes to fluid accumulation and may contribute to otalgia. Patients with a history of respiratory allergies have a higher incidence of recurrent effusions. Management of underlying allergic conditions, including use of antihistamines and nasal corticosteroids when appropriate, can assist in resolution of effusion and prevention of recurrences. Investigation of allergies should be considered in cases of recurrent or persistent effusion.
8. What are the potential complications if untreated?
Although many cases of otalgia and effusion resolve spontaneously, lack of appropriate follow-up can lead to complications. Persistent effusion can result in prolonged conductive hearing loss, which in children may affect language development and school performance. There is risk of progression to chronic otitis media with permanent changes to the tympanic membrane. Uninvestigated otalgia may be a symptom of more serious underlying conditions that require specific treatment. Long-duration effusions may lead to structural changes of the middle ear, including tympanic atelectasis or cholesteatoma formation in extreme cases. For these reasons, appropriate medical follow-up and reevaluation as recommended are essential to prevent complications and ensure adequate resolution.
Conclusion:
The ICD-11 code AB70 represents an important tool for appropriately documenting clinical presentations of otalgia and ear effusion that do not fit into more specific diagnostic categories. Correct coding requires complete clinical assessment, careful differentiation from other auricular conditions, and detailed documentation of findings. Understanding when to use and when not to use this code is essential to ensure diagnostic accuracy, effective communication between professionals, and quality of health data. Appropriate application of AB70 contributes to adequate patient management and to the epidemiological understanding of these common conditions in clinical practice.
External References
This article was prepared based on reliable scientific sources:
- 🌍 WHO ICD-11 - Otalgia or ear effusion
- 🔬 PubMed Research on Otalgia or ear effusion
- 🌍 WHO Health Topics
- 📊 Clinical Evidence: Otalgia or ear effusion
- 📋 Ministry of Health - Brazil
- 📊 Cochrane Systematic Reviews
References verified on 2026-02-03